OptiNose, Inc. (OPTN)

USD 8.99

(-1.21%)

Total Assets Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual total assets in 2023 was 107.72 Million USD , down -25.3% from previous year.
  • OptiNose, Inc.'s latest quarterly total assets in 2024 Q2 was 131.87 Million USD , up 57.54% from previous quarter.
  • OptiNose, Inc. reported annual total assets of 144.22 Million USD in 2022, down -13.16% from previous year.
  • OptiNose, Inc. reported annual total assets of 166.07 Million USD in 2021, down -12.04% from previous year.
  • OptiNose, Inc. reported quarterly total assets of 83.7 Million USD for 2024 Q1, down -22.3% from previous quarter.
  • OptiNose, Inc. reported quarterly total assets of 107.72 Million USD for 2023 Q4, up 6.23% from previous quarter.

Annual Total Assets Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Total Assets of OptiNose, Inc. (2023 - 2015)

Year Total Assets Total Assets Growth
2023 107.72 Million USD -25.3%
2022 144.22 Million USD -13.16%
2021 166.07 Million USD -12.04%
2020 188.81 Million USD 9.36%
2019 172.65 Million USD -20.43%
2018 216.98 Million USD -10.01%
2017 241.13 Million USD 480.34%
2016 41.55 Million USD 159.55%
2015 16 Million USD 0.0%

Peer Total Assets Comparison of OptiNose, Inc.

Name Total Assets Total Assets Difference
Cosmos Health Inc. 66.29 Million USD -62.498%
Safety Shot Inc 12.7 Million USD -747.647%
Bright Green Corporation 17.4 Million USD -519.024%
Embecta Corp. 1.21 Billion USD 91.129%
ANI Pharmaceuticals, Inc. 904.42 Million USD 88.089%
Aquestive Therapeutics, Inc. 57.41 Million USD -87.622%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 90.577%
Dynavax Technologies Corporation 997.09 Million USD 89.196%
Esperion Therapeutics, Inc. 205.79 Million USD 47.653%
Intra-Cellular Therapies, Inc. 728.29 Million USD 85.208%
Pacira BioSciences, Inc. 1.57 Billion USD 93.157%
PainReform Ltd. 9.93 Million USD -984.884%
Sunshine Biopharma, Inc. 27.34 Million USD -293.934%
Sunshine Biopharma, Inc. 27.34 Million USD -293.934%
SCYNEXIS, Inc. 128.41 Million USD 16.107%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -365.814%
Journey Medical Corporation 76.84 Million USD -40.183%
Alpha Teknova, Inc. 128.58 Million USD 16.221%
Procaps Group, S.A. 460.18 Million USD 76.59%
Theratechnologies Inc. 77.76 Million USD -38.524%
Harrow Health, Inc. 311.75 Million USD 65.444%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -623.353%
Biofrontera Inc. 27.93 Million USD -285.683%
DURECT Corporation 45.18 Million USD -138.397%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 92.354%
Cronos Group Inc. 1.13 Billion USD 90.502%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 77.131%
Kala Pharmaceuticals, Inc. 55.94 Million USD -92.549%
RedHill Biopharma Ltd. 23.04 Million USD -367.429%
Organogenesis Holdings Inc. 460.02 Million USD 76.582%
Guardion Health Sciences, Inc. 11.91 Million USD -803.905%
Cumberland Pharmaceuticals Inc. 81.77 Million USD -31.737%
Radius Health, Inc. 1.71 Billion USD 93.722%
Universe Pharmaceuticals INC 53.28 Million USD -102.167%
ProPhase Labs, Inc. 91.92 Million USD -17.19%
Phibro Animal Health Corporation 982.18 Million USD 89.032%
Procaps Group S.A. 460.18 Million USD 76.59%
Alvotech 950.09 Million USD 88.661%
TherapeuticsMD, Inc. 43.3 Million USD -148.745%
Viatris Inc. 47.68 Billion USD 99.774%
Rockwell Medical, Inc. 52.17 Million USD -106.484%
Aytu BioPharma, Inc. 118.09 Million USD 8.778%
SIGA Technologies, Inc. 254.83 Million USD 57.726%
Tilray Brands, Inc. 4.33 Billion USD 97.515%
Lifecore Biomedical, Inc. 273.7 Million USD 60.64%
Shineco, Inc. 84.17 Million USD -27.976%
PetIQ, Inc. 868.22 Million USD 87.592%
Regencell Bioscience Holdings Limited 8.43 Million USD -1176.681%
Incannex Healthcare Limited 17.04 Million USD -531.953%
Neurocrine Biosciences, Inc. 3.25 Billion USD 96.687%
Alimera Sciences, Inc. 153.52 Million USD 29.829%
Silver Spike Investment Corp. 88.57 Million USD -21.623%
Assertio Holdings, Inc. 286.41 Million USD 62.388%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -1710.043%
Petros Pharmaceuticals, Inc. 33.79 Million USD -218.765%
Clever Leaves Holdings Inc. 31.24 Million USD -244.81%
Cyclo Therapeutics, Inc. 13.24 Million USD -713.2%
Avadel Pharmaceuticals plc 261.12 Million USD 58.744%
Hempacco Co., Inc. 18.04 Million USD -497.065%
Talphera, Inc. 20.39 Million USD -428.213%
Alvotech 950.09 Million USD 88.661%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 73.476%
Lantheus Holdings, Inc. 1.65 Billion USD 93.476%
Currenc Group, Inc. 141.49 Million USD 23.861%
Kamada Ltd. 351.96 Million USD 69.393%
Indivior PLC 1.95 Billion USD 94.479%
Evoke Pharma, Inc. 7.06 Million USD -1424.062%
Flora Growth Corp. 23.62 Million USD -355.976%
Cyclo Therapeutics, Inc. 13.24 Million USD -713.2%
Evolus, Inc. 188.99 Million USD 43.0%
HUTCHMED (China) Limited 1.27 Billion USD 91.582%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 92.879%
Akanda Corp. 8.83 Million USD -1118.655%